Preventing Hepatitis B Reactivation Due to Immunosuppressive Drug Treatments

被引：53
|
作者：
Perrillo, Robert P. [1 ]
Martin, Paul [2 ]
Lok, Anna S. [3 ]
机构：
[1] Baylor Univ, Med Ctr, Hepatol Div, Dallas, TX USA
[2] Univ Miami, Div Hepatol, Miami, FL USA
[3] Univ Michigan, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2015年 / 313卷 / 16期
关键词：
VIRUS REACTIVATION; INFECTION PRIOR; RECOMMENDATIONS; CHEMOTHERAPY; LAMIVUDINE; LYMPHOMA; AGENTS;
D O I：
10.1001/jama.2015.2571
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1617 / 1618
页数：2
相关论文
共 50 条
  • [31] Preventing Hepatitis B Reactivation in Immunosuppressed Patients: Is It Time to Revisit the Guidelines?
    Yazdany, Jinoos
    Calabrese, Leonard
    ARTHRITIS CARE & RESEARCH, 2010, 62 (05) : 585 - 589
  • [32] Could Hepatitis B Reactivation be Overlooked in Patients with Resolved Hepatitis B Virus Infection and Receiving Immunosuppressive Treatment?
    Acar, Sencan
    Eminler, Ahmet Tarik
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2024, 35 (04):
  • [33] Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy
    Su, Yi-Chia
    Lin, Pei-Chin
    Yu, Hsien-Chung
    Wu, Chih-Chien
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (08) : 925 - 929
  • [34] Reactivation of Hepatitis B Virus in Autoimmune Disease Patients Receiving Immunosuppressive Agents
    Kobayashi, Daisuke
    Ito, Satoshi
    Unno, Megumi
    Narita, Ichiei
    Murasawa, Akira
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S885 - S886
  • [35] American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
    Reddy, K. Rajender
    Beavers, Kimberly L.
    Hammond, Sarah P.
    Lim, Joseph K.
    Falck-Ytter, Yngve T.
    GASTROENTEROLOGY, 2015, 148 (01) : 215 - U351
  • [36] Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy
    María Luisa Manzano-Alonso
    Gregorio Castellano-Tortajada
    World Journal of Gastroenterology, 2011, 17 (12) : 1531 - 1537
  • [37] Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy
    Oketani, Makoto
    Ido, Akio
    Uto, Hirofumi
    Tsubouchi, Hirohito
    HEPATOLOGY RESEARCH, 2012, 42 (07) : 627 - 636
  • [38] Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy
    Luisa Manzano-Alonso, Maria
    Castellano-Tortajada, Gregorio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (12) : 1531 - 1537
  • [39] Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification
    Seto, Wai-Kay
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (06) : 825 - 830
  • [40] Lesson of the month 2: Severe reactivation of hepatitis B after immunosuppressive chemotherapy
    Dyson, Jessica Katharine
    Hudson, Mark
    McPherson, Stuart
    CLINICAL MEDICINE, 2014, 14 (05) : 551 - 555
12345